169 related articles for article (PubMed ID: 8659562)
41. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
[TBL] [Abstract][Full Text] [Related]
42. [Simple to use--superior adhesiveness].
MMW Fortschr Med; 2005 Dec; 147(51-52):75. PubMed ID: 16402720
[No Abstract] [Full Text] [Related]
43. Rapid switching between transdermal fentanyl and methadone in cancer patients.
Mercadante S; Ferrera P; Villari P; Casuccio A
J Clin Oncol; 2005 Aug; 23(22):5229-34. PubMed ID: 16051965
[TBL] [Abstract][Full Text] [Related]
44. Transdermal fentanyl: new preparation. An alternative to morphine.
Prescrire Int; 1998 Oct; 7(37):137-40. PubMed ID: 10915416
[TBL] [Abstract][Full Text] [Related]
45. [The Danish Medicines Agency should reconsider the criteria of generic substitution between fentanyl depot patches].
Christrup LL; Jensen NH; Jonsson T; Sjøgren P; Steffansen B
Ugeskr Laeger; 2009 Oct; 171(44):3215; author reply 3215. PubMed ID: 19866512
[No Abstract] [Full Text] [Related]
46. Switching from reservoir to matrix systems for the transdermal delivery of fentanyl: a prospective, multicenter pilot study in outpatients with chronic pain.
Freynhagen R; von Giesen HJ; Busche P; Sabatowski R; Konrad C; Grond S
J Pain Symptom Manage; 2005 Sep; 30(3):289-97. PubMed ID: 16183013
[TBL] [Abstract][Full Text] [Related]
47. Failure of pain control using transdermal fentanyl during rifampicin treatment.
Morii H; Chiba M; Konishi H; Endo Y; Yamaji A
J Pain Symptom Manage; 2007 Jan; 33(1):5-6. PubMed ID: 17196900
[No Abstract] [Full Text] [Related]
48. Opioid-induced respiratory depression resulting from transdermal fentanyl-clarithromycin drug interaction in a patient with advanced COPD.
Horton R; Barber C
J Pain Symptom Manage; 2009 Jun; 37(6):e2-5. PubMed ID: 19500718
[No Abstract] [Full Text] [Related]
49. From codeine to transdermal fentanyl for cancer pain control: a safety and efficacy clinical trial.
Mystakidou K; Befon S; Kouskouni E; Gerolymatos K; Georgaki S; Tsilika E; Vlahos L
Anticancer Res; 2001; 21(3C):2225-30. PubMed ID: 11501851
[TBL] [Abstract][Full Text] [Related]
50. Transdermal fentanyl in cancer patients with moderate-to-severe pain: a prospective examination.
Iconomou G; Viha A; Vagenakis AG; Kalofonos HP
Anticancer Res; 2000; 20(6C):4821-4. PubMed ID: 11205226
[TBL] [Abstract][Full Text] [Related]
51. Effect of local administration of transdermal fentanyl on peripheral opioid analgesia.
Worrich S; Schuler G; Janicki PK
Pain Med; 2007; 8(1):41-7. PubMed ID: 17244103
[TBL] [Abstract][Full Text] [Related]
52. [Tumor pain. Fentanyl TTS: a transdermal system for tumor pain therapy].
Dtsch Med Wochenschr; 1995 Oct; 120(41 Suppl):1-4. PubMed ID: 9022357
[No Abstract] [Full Text] [Related]
53. Pain patch.
Seccareccia D
Can Fam Physician; 2007 Sep; 53(9):1447-8. PubMed ID: 17872872
[No Abstract] [Full Text] [Related]
54. Rifampin reduces the analgesic effect of transdermal fentanyl.
Takane H; Nosaka A; Wakushima H; Hosokawa K; Ieiri I
Ann Pharmacother; 2005 Dec; 39(12):2139-40. PubMed ID: 16288064
[No Abstract] [Full Text] [Related]
55. Fentanyl buccal tablet (Fentora) for breakthrough pain.
Med Lett Drugs Ther; 2007 Sep; 49(1270):78-9. PubMed ID: 17878889
[No Abstract] [Full Text] [Related]
56. Fentanyl patch sufficient analgesia for only one day.
Sasson M; Shvartzman P
J Pain Symptom Manage; 2006 May; 31(5):389-91. PubMed ID: 16716868
[No Abstract] [Full Text] [Related]
57. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
58. [Clinical trials: early use of transdermal opioid therapy].
MMW Fortschr Med; 2005 Apr; 147(17):64-5. PubMed ID: 15906440
[No Abstract] [Full Text] [Related]
59. Transdermal fentanyl (Duragesic): respiratory arrest in adolescents.
Raymond B; Morawiecka I
CMAJ; 2004 Oct; 171(8):991-2. PubMed ID: 15497207
[No Abstract] [Full Text] [Related]
60. Use of dexmedetomidine to discontinue high-dose fentanyl.
Youngblood FE; Knaak E; Rose J; Malesker MA
Ann Pharmacother; 2011 Dec; 45(12):1589-90. PubMed ID: 22068243
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
